Description:

Study ID: 110159 Clinical Study ID: 110159 Study Title: A Randomised, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Assess the Efficacy and Safety of Single Dose Intranasal GSK1004723 Compared With Placebo in an Allergen Challenge Chamber in Male Subjects With Seasonal Allergic Rhinitis Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00824356 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, GSK1004723 (200mg), GSK1004723 (1000mg) Study Indication: Allergic Rhinitis

Keywords:
Versions (1) ▾
  1. 3/2/21
Copyright Holder:
GlaxoSmithKline
Uploaded on:

March 2, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Efficacy and Safety of Single Dose Intranasal GSK1004723 in an Allergen Challenge Chamber NCT00824356

Follow-Up - Pregnancy Information; Status of Treatment Blind, Study Conclusion

Pregnancy Information
Did a female partner of the male subject become pregnant during the study?
Status of Treatment Blind
Was the treatment blind broken during the study?
Reason blind broken
Study Conclusion
Was the subject withdrawn from the study?
Primary reason for withdrawal
Case book ready for signature

Similar models